BioSpace News Archive

The TGH Virtual Health Kit, powered by TytoCare, will help bring convenient and innovative health care directly to patients at home

Nearly 50 years after its inception, the Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, unveils a rebranded chapter program, “Lulie’s Next Chapter for Light & Vision.”

Statistically significant results from the pivotal Phase III LINC-4 study demonstrate that Isturisa® provides rapid and sustained normalization of mean urinary free cortisol levels in the majority of patients.

Additional Novel Research Programs Advancing via COMPASS in Cardio/Renal, Cardiovascular, Neurology, Ophthalmic and Metabolic Diseases

First oncology product candidate identified using the company’s human memory B-cell platform, and intended for potential treatment of solid tumors

Cis-targeting technology aims to enable precise targeting of discrete beneficial immune cell subtypes with a novel class of biotherapeutics and avoid unwanted effects driven by other cell-types

CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, announce the closing of a strategic development and commercial collaboration agreement, as well as CellMax’s Series C financing.

JCR Pharmaceuticals Announces Approval of IZCARGO ® (Pabinafusp Alfa) for Treatment of MPS II (Hunter Syndrome) in Japan - First Approved Enzyme Replacement Therapy for MPS II to Penetrate Blood-Brain Barrier via Intravenous Administration, Validating JCR’s J-Brain Cargo ® Technology -

Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics, today announced its intent to launch Virtual Physician™ focused on telehealth solutions for regenerative medicine this summer.

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Tuesday, March 30, 2021, to review its financial results for the year ended December 31, 2020 and to provide a Company update.